Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Published in: CNS Drugs 3/2001

01-03-2001 | Therapy in Practice

Kleptomania

Diagnosis and Treatment Options

Authors: Dr Rimona Durst, Gregory Katz, Alexander Teitelbaum, Josef Zislin, Pinhas N. Dannon

Published in: CNS Drugs | Issue 3/2001

Login to get access

Abstract

Kleptomania — the inability to resist the impulse to steal objects, not for personal use or monetary gain — is currently classified in psychiatric nomenclature as an impulse control disorder. However, some of the principle features of the disorder, which include repetitive intrusion thoughts, inability to resist the compulsion to perform the thievery and the relief of tension following the act, suggest that kleptomania may constitute an obsessive-compulsive spectrum disorder.
Kleptomania is commonly under-diagnosed and is often accompanied by other psychiatric conditions, most notably affective, anxiety and eating disorders, and alcohol and substance abuse. Individuals with the disorder are usually referred for treatment due to the comorbid psychiatric complaints rather than kleptomanic behaviour per se.
Over the past century there has been a shift from psychotherapeutic to psychopharmacological interventions for kleptomania. Pharmacological management using selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs) and other antidepressants, mood stabilisers and opioid receptor antagonists, as adjuvants to cognitive-behavioural therapy, has produced promising results.
Literature
1.
Seguier H. Revue historique de la notion de kleptomania. L’Encephale 1966; 55: 336–69PubMed
2.
Seguier H. Revue historique de la notion de kleptomania. L’Encephale 1966; 55: 452–66
3.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
4.
World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992
5.
NcNeilly DP, Burke WJ. Stealing lately: a case of late-onset kleptomania. Int J Geriatr Psychiatry 1998; 13: 116–21CrossRef
6.
McElroy SL, Keck Jr PE, Phillips KA. Kleptomania, compulsive buying, and binge-eating disorder. J Clin Psychiatry 1995; 56(4 Suppl.): 14–26PubMed
7.
Lepkifker E, Dannon PN, Ziv R, et al. The treatment of kleptomania with serotonin reuptake inhibitors. Clin Neuropharmacol 1999; 22: 40–3CrossRefPubMed
8.
Goldman MJ. Kleptomania making sense of the nonsensical. Am J Psychiatry 1991; 148: 986–96PubMed
9.
Bradford J, Balmaceda R. Shoplifting: is there a specific psychiatric syndrome? Can J Psychiatry 1983; 28: 248–54PubMed
10.
Goldman MJ. Kleptomania: An overview. Psychiatric Annals 1992; 22: 68–71
11.
Arieti S. American handbook of psychiatry. New York (NY): Basic Books, 1960
12.
Gudjonsson GH. The significance of depression in the mechanism of ‘compulsive’ shoplifting. Med Sci Law 1987; 27(3): 171–6PubMed
13.
McElroy SL, Keck PL, Pope HG, et al. Kleptomania: clinical characteristics and associated psychopathology. Psychol Med 1991; 21: 93–108CrossRefPubMed
14.
Baum A, Goldner EM. The relationship between stealing and eating disorders: a review. Har Rev Psychiatry 1995; 3(4): 210–21CrossRef
15.
Sarasalo E, Bergman B, Toth J. Personality traits and somatic morbidity among kleptomaniacs. Acta Psychiatr Scand 1996; 94: 358–64CrossRefPubMed
16.
Janet P. La kleptomanie et la depression mentale. J de Psychologie Normale et Pathologique 1911; 8: 97–103
17.
18.
Fishbain DA. Kleptomania as a risk taking behavior in response to depression. Am J Psychotherapy 1987; 41: 598–603
19.
Durst R, Katz G, Knobler HY. Buspirone augmentation of fluvoxamine in the treatment of kleptomania. J Nerv Ment Dis 1997; 185(9): 586–8CrossRefPubMed
20.
McElroy SL, Pope HG, Hudson JL, et al. Kleptomania: a report of 20 cases. Am J Psychiatry 1991; 148: 652–7PubMed
21.
Hudson JL, Pope HG. An affective spectrum disorder. Am J Psychiatry 1990; 147: 552–6PubMed
22.
Pope HG, Hudson JI. A supplemental interview for forms of affective spectrum disorder. Int J Psychiatry Med 1991; 21: 205–35CrossRefPubMed
23.
McElroy SL, Keck PE, Pope HG, et al. Pharmacological treatment of kleptomania and bulimia nervosa. Clin Psychopharmacol 1989; 358–60
24.
McElroy SL, Hudson JL, Pope HG, et al. The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationships to other psychiatric disorders. Am J Psychiatry 1992; 149: 318–27PubMed
25.
Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 1995; 56(4 Suppl.): 3–6PubMed
26.
Koran LM. Obsessive-compulsive and related disorders in adults. Cambridge: Cambridge University Press, 1999
27.
Lacassagne A. Les rols a l’etage et dans les grands magasins. Congres International d’Anthropologie Criminelle [Rapports]; Georg: Geneve: 1896; 4: 396
28.
Dupouy R. De la kleptomanie. J Psychologie Normale et Pathologique 1905; 2: 404–26
29.
Esquirol E. Des maladies mentales. Paris: Balliere, 1838
30.
Stekel W. Compulsion and doubt. New York (NY): Washington Square Press, 1967
31.
Fenichel O. Acting out: the yearbook of psychoanalysis. London: Imago Publishing, 1946
32.
Bleuler E. Textbook of psychiatry. New York (NY): Macmillan, 1924: 538–40
33.
34.
Elizur A, Jaffe R. Stealing as a pathological symptom. Isr Ann Psychiatry Relat Discipl 1968; 6(1): 52–61
35.
Aggernaes M. A study of kleptomania with illustrative cases. Acta Psychiatr Neuro Scand 1961; 36: 1–46CrossRef
36.
Glover JH. A case of kleptomania treated by covert sensitization. Br J Clin Psychol 1985; 24: 213–4CrossRefPubMed
37.
Shohier JJ. A rather ordinary crime: shoplifting. International Criminal Police 1969; 299: 161–6
38.
Stekel W. The sexual root of kleptomania. J Am Institut Crim Law Crimonol 1911; 12: 239–46CrossRef
39.
Allen A. Stealing as a defense. Psychiatr Q 1965; 34: 572–83
40.
Levy E. Psychoanalytic treatment of a child with a stealing compulsion. Am J Orthopsychiatry 1934; 4: 1–23CrossRef
41.
Meyer TJ. Acontribution to the psychopathology of shoplifting. J Forensic Sci 1970; 13: 295–310
42.
Fenichel O. The psychoanalytic theory of neurosis. New York (NY): WW Norton, 1945
43.
Adler A. The individual psychology of Alfred Adler. In: Ansbacher HL, Ansbacher RR, editors. The individual psychology of Alfred Adler. New York (NY): Basic Books Inc., 1956
44.
Wannann WA. The use of aversion therapy to treat kleptomania. Psychopathologie Africaine 1980; 16(1): 77–82
45.
46.
Marzagao LR. Systematic desensitization treatment of kleptomania. J Behav Ther Exp Psychiatry 1972; 3(4): 327–8CrossRef
47.
McConaghy N, Blaszczynski A. Imaginal desensitization: a cost-effective treatment in two shop-lifters and a binge-eater resistant to previous therapy. Aust N Z J Psychiatry 1988; 22: 78–82CrossRefPubMed
48.
Guidry LS. Use of covert punishing contingency in compulsive stealing. J Behav Ther Exp Psychiatry 1969; 6: 169CrossRef
49.
Gauthier J, Pellerin D. Management of compulsive shoplifting through covert sensitization. J Behav Ther Exp Psychiatry 1982; 13: 73–5CrossRefPubMed
50.
Christenson GA, Crow SJ. The characterization and treatment of trichotilomania. J Clin Psychiatry 1996; 57(8 Suppl.): 42–7PubMed
51.
DeCaria CM, Hollander E, Grossman R, et al. Diagnosis, neurobiology, and treatment of pathological gambling. J Clin Psychiatry 1996; 57(8 Suppl.): 42–7
52.
Tynes LL, White K, Steketee GS. Towards a new nosology of obsessive-compulsive disorder. Comp Psychiatry 1990; 31: 465–80CrossRef
53.
Marazziti D, Dell’Osso L, Presta S, et al. Platelet [3H] paroxetine binding in patients with OCD-related disorders. Psychiatry Res 1999; 27: 89 (3): 223-8
54.
Schwartz JH. Psychoanalytic psychotherapy for a woman with diagnosis of kleptomania. Hosp Community Psychiatry 1992; 43: 109–10PubMed
55.
Burstein A. Fluoxetine-lithium treatment for kleptomania. J Clin Psychiatry 1992; 53(1): 28–9PubMed
56.
Chong SA, Low BL. Treatment of kleptomania with fluvoxamine. Acta Psychiatr Scand 1996; 93; 314–5CrossRefPubMed
57.
Dannon PN, Ianco I, Grunhaus L. Naltrexone treatment in kleptomanic patients. Human Psychopharm 1999; 14: 583–5CrossRef
58.
Kindler S, Dannon PN, Iancu I, et al. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. Clin Neuropharmacol. 1997; 20(2): 126–9CrossRefPubMed
59.
60.
Fishbain DA. Kleptomanie behavior response to perphenazine-amitriptyline HCL combination. Can J Psychiatry 1988; 33: 241–2PubMed
61.
Priest RG, Gimbrett R, Roberts M, et al. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. Acta Psychiatr Scand Suppl 1995; 386: 40–3CrossRef
62.
Kmetz GF, McElroy SL, Collins DJ. Response of kleptomania and mixed mania to valproate. Am J Psychiatry 1997; 154: 580–1PubMed
63.
Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998; 59: 159–64CrossRefPubMed
64.
Volpicelli JR, Clay KL, Watson NT, et al. Naltrexone in the treatment of alcoholism. J Clin Psychiatry 1995; 56(7 Suppl.): 39–44PubMed
65.
Ramelli E, Mapelli G. Du vol Melancholique. Acta Psychiat Belg 1979; 79: 56–74
66.
Zorick FJ, Salis PJ, Roth T, et al. Narcolepsy and automatic behavior: a case report. J Clin Psychiatry 1979; 40(4): 194–7PubMed
Metadata
Title
Kleptomania
Diagnosis and Treatment Options
Authors
Dr Rimona Durst
Gregory Katz
Alexander Teitelbaum
Josef Zislin
Pinhas N. Dannon
Publication date
01-03-2001
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 3/2001
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-200115030-00003

Other articles of this Issue 3/2001

CNS Drugs 3/2001 Go to the issue

Therapy in Practice

Psychotic and Mood Disorders Associated with the Perimenopausal Period

Adis Drug Evaluation

Tianeptine

Current Opinion

Neuroprotection for Ischaemic Stroke

Review Article

Occupational Exposure to Volatile Anaesthetics

Review Article

Visual Field Defects with Vigabatrin